Twin Peaks Wealth Advisors LLC Invests $872,000 in Doximity, Inc. (NASDAQ:DOCS)

Twin Peaks Wealth Advisors LLC acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,011 shares of the company's stock, valued at approximately $872,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC bought a new position in Doximity during the first quarter valued at about $583,000. State of Michigan Retirement System grew its stake in shares of Doximity by 6.0% in the 1st quarter. State of Michigan Retirement System now owns 30,000 shares of the company's stock worth $807,000 after purchasing an additional 1,700 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of Doximity in the 1st quarter worth approximately $416,000. Retirement Systems of Alabama lifted its stake in Doximity by 3.7% during the first quarter. Retirement Systems of Alabama now owns 153,406 shares of the company's stock valued at $4,128,000 after purchasing an additional 5,417 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Doximity by 78.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 212,886 shares of the company's stock valued at $5,729,000 after buying an additional 93,718 shares in the last quarter. Institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

Shares of Doximity stock traded up $0.11 on Wednesday, reaching $41.99. The stock had a trading volume of 817,060 shares, compared to its average volume of 1,670,991. The business's 50-day moving average price is $40.32 and its two-hundred day moving average price is $32.08. The stock has a market cap of $7.80 billion, a P/E ratio of 52.34, a price-to-earnings-growth ratio of 5.29 and a beta of 1.29. Doximity, Inc. has a fifty-two week low of $19.89 and a fifty-two week high of $44.88.

Doximity (NASDAQ:DOCS - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. The firm had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. As a group, equities analysts forecast that Doximity, Inc. will post 0.8 earnings per share for the current fiscal year.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 2,500 shares of the business's stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $28.18, for a total transaction of $70,450.00. Following the transaction, the director now owns 10,258 shares of the company's stock, valued at approximately $289,070.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Kira Scherer Wampler sold 2,500 shares of the company's stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the sale, the director now owns 10,258 shares of the company's stock, valued at $289,070.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Anna Bryson sold 30,000 shares of the firm's stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the transaction, the chief financial officer now owns 309,627 shares of the company's stock, valued at approximately $10,836,945. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,511 shares of company stock worth $1,146,271 over the last three months. 37.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on DOCS shares. JPMorgan Chase & Co. upped their target price on Doximity from $27.00 to $30.00 and gave the company a "neutral" rating in a report on Monday, August 19th. Baird R W raised shares of Doximity to a "strong-buy" rating in a research note on Tuesday, September 17th. Bank of America increased their price objective on Doximity from $32.00 to $45.00 and gave the stock a "neutral" rating in a research note on Monday, October 7th. Wells Fargo & Company downgraded Doximity from an "equal weight" rating to an "underweight" rating and dropped their target price for the company from $27.00 to $19.00 in a report on Thursday, July 18th. Finally, Canaccord Genuity Group increased their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a "buy" rating in a research report on Tuesday, August 20th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $36.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.